Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803)

詳細情報 詳細情報について

• CRID

  1360574094769986688

• DOI

  10.1093/annonc/mds529

• ISSN

  09237534

• Web Site

  https://api.elsevier.com/content/article/PII:S0923753419371753?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0923753419371753?httpAccept=text/plain

  http://academic.oup.com/annonc/article-pdf/24/4/993/716547/mds529.pdf

• データソース種別

  • Crossref